Background: Primary tic disorders (TD) are common movement disorders in childhood. However, it is unclear if international guidelines are applied in Latin America.
Objectives: To investigate the applicability of TD guidelines in Latin America.
Methods: An online survey was developed and distributed to healthcare professionals treating TD across Latin America.
Results: Healthcare providers from 15 countries participated. TD are mainly diagnosed by general neurologists (85%). There is limited access to public clinics for movement disorders or TD, and 80% do not utilize a protocol. Rating scales are rarely used. More than half reported being unaware of resources for psychoeducation. Non-pharmacological interventions for TD and alpha agonists are unavailable in several countries. Consequently, antipsychotics are the first line treatment.
Conclusions: The ubiquity of TD diagnosis throughout Latin America is a positive aspect, however barriers like limited referral pathways, lack of awareness about tics and treatment options do exist. This highlights the need for more effective pathways for TD in Latin America.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/mdc3.70020 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Assisted Reproductive Technologies in Latin America: the Latin American Registry, 2021.
JBRA Assist Reprod
March 2025
IVI Panama, Ciudad de Panama, Panama.
Research Question: What are the trends and impact of new technologies on the effectiveness and safety of assisted reproductive technology (ART) performed in Latin America during 2021?
Design: This was a retrospective collection of cycle-based multinational data obtained from ART procedures performed by 204 accredited institutions in 16 countries.
Results: In total 127,351 initiated cycles resulted in 20,032 deliveries and 22,708 births. ART utilization showed great variability, from 623.
Assessing the global dengue burden: Incidence, mortality, and disability trends over three decades.
PLoS Negl Trop Dis
March 2025
Department of Pathogen Biology, Anhui Province Key Laboratory of Zoonoses, The Provincial Key Laboratory of Zoonoses of High Institutions in Anhui, School of Basic Medical Sciences, Anhui Medical University, Hefei, China.
Background: Dengue, the fastest-spreading vector-borne disease (VBD), significantly burdens global health systems. This study analyzed the trends in the global burden of dengue from 1990 to 2021, utilizing data from the Global Burden of Diseases, Injuries, and Risk Factors Study 2021 (GBD 2021).
Methodology/principal Findings: We retrieved data from GBD 2021 regarding dengue, including the number of incidences and age-standardized incidence rate (ASIR), the number of deaths and age-standardized death rate (ASDR), disability-adjusted life-years (DALYs) and age-standardized DALYs.
A global cross-sectional survey on neonatal analgosedation: unveiling global trends and challenges through latent class analysis.
Eur J Pediatr
March 2025
Neonatal Intensive Care Unit, Clínica Universidad de Navarra, Madrid, Spain.
Purpose: This study aims to analyze global prescribing patterns for analgosedation in neonates during four critical care scenarios. The research explores existing patterns, their association with geographic and sociodemographic index (SDI), and adherence to evidence-based practices.
Methods: Data from a 2024 global survey of 924 responses to 28 questions were analyzed, focusing on four items for their high variability: premedication in intubation (Q17), sedation in preterm (Q19) and full-term newborns (Q23), and perinatal asphyxia (Q26).
Acceptability of VloV, a Mobile App Developed in Latin America for People with Substance Use Disorder among an Intensive Outpatient Treatment.
Actas Esp Psiquiatr
March 2025
Dispositivo Pavlovsky, C1425EFD Ciudad Autónoma de Buenos Aires, Argentina.
Background: Digital therapeutic tools seem to be helpful for substance use disorders (SUD), but there are few studies in Latin America about this approach. Our group of therapists developed VloV (an abbreviation for Pavlovsky), a mobile app that attempts to digitize practical tools along with strengthening the therapeutic alliance and user practice.
Method: We conducted a mixed-method pilot study between August 2021 and January 2022 to collect data about the patient experience using VloV and the therapeutic alliance among 23 patients.
Updates on HIV Pre-exposure Prophylaxis in Latin America: Available Drugs and Implementation Status.
Infez Med
March 2025
Division of Infectious Diseases, Department of Medicine, Miller School of Medicine, University of Miami, Miami, FL 33136, USA.
Latin America has reported a 9% increase in new HIV infections from 2010 to 2023. Pre-exposure prophylaxis (PrEP) is a crucial biomedical intervention for preventing HIV transmission. Currently, several antiretroviral drugs, in various forms of administration, have demonstrated high efficacy and effectiveness to protect against HIV.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!